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Introduction {#sec1}
============

The adult mammary gland undergoes cycles of proliferation, differentiation, and regression with every pregnancy. Mammary epithelial progenitor cells initially undergo rapid proliferation during pregnancy before differentiation into specialized milk-producing alveolar cells during lactation. ([@bib41]). We have shown previously that proliferation of alveolar cells during pregnancy is reduced when the transcription factor Stat6 is ablated ([@bib17]). Microarray analysis identified the Krüppel-associated box (KRAB) zinc finger protein, Zfp157 (herein called Roma---regulator of mammary alveologenesis), as the most highly upregulated gene in *Stat6*^*−/−*^ mammary glands at day 5 gestation (5dG). KRAB-Zfps constitute the largest family of transcriptional regulators, are found only in tetrapods, and are generally transcriptional repressors ([@bib39]). Various functions for these DNA binding proteins are just beginning to be elucidated ([@bib23]).

Generation of a Roma-LacZ reporter/functional knockout (hereafter named *Roma*^*−/−*^) mouse revealed, as anticipated, accelerated alveologenesis in pregnant females in concert with elevated levels of proliferation ([@bib29]). Unexpectedly, the ratio of ERα/PR/Gata3-expressing cells to pStat5 cells was dramatically skewed in favor of the latter when Roma was ablated. Both Stat5 and Gata3 are essential transcription factors for pregnancy-induced development and ablation of Gata3 from luminal epithelium during gestation results in lactation failure arising from death of epithelial cells ([@bib2], [@bib20]). Surprisingly, this lactation failure was rescued by coincident loss of Roma. Thus, we concluded that Roma is a master regulator of the alveolar lineage and that Gata3 is superfluous when Roma is not expressed ([@bib29]). However, the role of Roma in cell-cycle progression has not been investigated.

The cell cycle is exquisitely regulated by formation of unique cyclin and cyclin-dependent kinase (CDK) complexes that regulate entry into and drive progression of, different phases of the cell cycle. CDK function is tightly regulated by p21^Cip1^ and downregulation or loss of p21^Cip1^ is often associated with cell-cycle dysregulation and aberrant proliferation ([@bib7]). Furthermore, p21^Cip1^ is a critical enforcer of the G1 and G2 checkpoints ([@bib32]) and is a component of p53-mediated responses, and its downregulation compromises the cellular response to stress. Although much effort has been expended to determine mechanisms of p21^Cip1^ regulation, our understanding of p21^Cip1^ regulation in the cell cycle is incomplete.

The accurate and precise duplication of DNA occurs during S phase and to ensure that the genome is duplicated only once; coordinated licensing and initiation of replication origins is critical ([@bib5]). Geminin is a major inhibitor of replication licensing that prevents excessive firing and unscheduled re-firing of origins ([@bib19]). Furthermore, modulation of replication fork velocity is important to circumvent failure to duplicate genomic regions harboring natural barriers, and p21^Cip1^ has been implicated in assisting replication at such regions ([@bib15]). Other factors that regulate fork progression include the Cdc45-GINS-Mcm2--7 (CMG) helicase and DNA topoisomerases. These unwind DNA, resolve topological tension, and maintain DNA polymerase processivity in concert with proliferating cell nuclear antigen (PCNA). Dysregulation of these events results in re-replication, replication stress, aneuploidy, and genomic instability, significant events in tumorigenesis and tumor heterogeneity ([@bib6]). Here, we show that Roma is a critical component of the mammalian cell cycle that controls replication dynamics and cell-cycle progression.

Results {#sec2}
=======

Ablation of Roma Leads to Uncontrolled Proliferation and Prevents Developmentally Programmed Cell-Cycle Exit {#sec2.1}
------------------------------------------------------------------------------------------------------------

We have previously shown that ablation of Roma results in hyperproliferation of MECs in early pregnancy. This is not due to changes in systemic hormones, and, although the rate of ductal elongation is accelerated in pubertal *Roma*^*−/−*^ mice, there are no obvious defects in adult glands (data not shown). The increase in proliferation in *Roma*^*−/−*^ glands at 5dG was further supported by an increased proportion of 5-ethynyl-2′-deoxyuridine (EdU) positive mammary epithelial cells (MECs) ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A). Notably, at 10 days lactation (10dL) when cells are terminally differentiated ([@bib9]) and non-proliferative in control glands ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A), proliferation is still evident in *Roma*^*−/−*^ glands, suggesting that Roma is required for the transition from cell-cycle progression to quiescence. Increased EdU labeling was evident also in intestine, spleen, and thymus of young *Roma*^*−/−*^ mice ([Figure S1](#mmc1){ref-type="supplementary-material"}B).

Immunoblot analysis of 10dL mammary tissue extracts revealed an increase in levels of replication licensing proteins (Cdc6, Cdt1, and Mcm3) and replisome components (Cdc45 and GINS) ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}D), while the licensing inhibitor geminin was strikingly downregulated at protein and RNA levels ([Figures 1](#fig1){ref-type="fig"}B and 1C). This pattern is consistent with failure to downregulate replication licensing for cell-cycle exit ([@bib5]). Furthermore, *Roma*^*−/−*^ MECs at 10dG were found to be undergoing aberrant re-replication (data not shown), a process suppressed by geminin ([@bib25]). Immunofluorescence analysis revealed a significant increase in cells expressing Ki67 and PCNA in *Roma*^*−/−*^ 10dL glands ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Interestingly, we observed more binucleated cells in *Roma*^*−/−*^ in comparison to wild-type (WT) glands ([Figure 1](#fig1){ref-type="fig"}D), indicating cytokinesis failure. The relative increase in Cdh1 levels compared to Cdc20 in *Roma*^*−/−*^ MECs ([Figure 1](#fig1){ref-type="fig"}E) could contribute to mitotic slippage ([@bib10]). This possibility is supported by elevated levels of securin and the mitotic kinases Aurora A and Plk1 ([Figure 1](#fig1){ref-type="fig"}E) that could impede sister chromatid separation ([@bib30]). To investigate further, we performed karyotype analysis on cells from WT and *Roma*^*−/−*^ glands after a full lactation and natural wean and found that Roma deficiency correlated with an approximately 4-fold increase in tetraploidy ([Figure 1](#fig1){ref-type="fig"}F). This suggests that the unscheduled proliferation during lactation leads to cell-cycle dysregulation, with chromosomal missegregation and instability.

Unscheduled Proliferation in the Absence of *Roma* Leads to Replication Stress and Activation of the DNA Damage Response {#sec2.2}
------------------------------------------------------------------------------------------------------------------------

Replication stress results in phosphorylation of the ssDNA binding protein RPA2 on residue T21 by the ATR/Chk1 kinases. We noted RPA2 (pT21) foci by immunofluorescence analysis of 10dL *Roma*^*−/−*^ glands ([Figure 2](#fig2){ref-type="fig"}A). Furthermore, collapse of stalled forks to form double-strand breaks (DSBs) is evidenced by γH2AX foci and presence of large 53BP1 foci ([Figure 2](#fig2){ref-type="fig"}A), reminiscent of 53BP1-OPT domains observed in G1 cells ([@bib14]) that mark replication stress-mediated DNA lesions arising from the previous S phase ([@bib22]). Immunoblot analysis revealed activation of ATR-Chk1-driven S and G2 phase checkpoints and p53 activation as evidenced by p53 (pS15) levels and upregulation of Gadd45 ([Figures 2](#fig2){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}A). Intriguingly, another major downstream target of p53, p21^Cip1^, which is an important effector of cell-cycle arrest upon checkpoint activation, is not correspondingly upregulated in the absence of *Roma* ([Figure 2](#fig2){ref-type="fig"}B). Indeed, quantitative real-time PCR analysis indicated that p21^Cip1^ was transcriptionally downregulated in *Roma*^*−/−*^ glands compared to WT ([Figure 2](#fig2){ref-type="fig"}C). RNA levels of other DNA damage responders such as Blm, Fen1, and Rrm1, which localize to stalled forks are also upregulated ([Figure S2](#mmc1){ref-type="supplementary-material"}B).

These data indicate that Roma insufficiency results in unscheduled proliferation, replication stress, and DNA damage, which would activate the G2/M checkpoint. A key player is Wee1, which negatively regulates CDK1 to prevent mitosis ([@bib21]), and Wee1 levels are diminished in *Roma*^*−/−*^ mammary glands ([Figure 1](#fig1){ref-type="fig"}E). The increased proportion of binucleated cells upon *Roma* loss ([Figure 1](#fig1){ref-type="fig"}D) further supports the notion of defects in G2/M checkpoint arrest and/or checkpoint bypass probably arising from the decreased levels of Wee1 and p21^Cip1^.

Hence, it is not surprising that we observed an increase in gross structural chromosomal rearrangements in *Roma*^*−/−*^ glands compared to WT ([Figures 2](#fig2){ref-type="fig"}D and [S2](#mmc1){ref-type="supplementary-material"}C). Such genomic damage could arise from DNA replication errors and/or S phase checkpoint defects ([@bib27]). Since key genes such as p21^Cip1^ and geminin are transcriptionally dysregulated in the absence of *Roma*, these effects could be mediated initially at the transcriptional level via recruitment of Roma and additional co-factors, such as KAP-1, to the promoters of a subset of these genes.

Roma Regulates Replication Fork Dynamics {#sec2.3}
----------------------------------------

These data highlight a role for Roma in cell-cycle regulation. To facilitate mechanistic analysis, we derived primary mouse embryonic fibroblasts (MEFs) from WT and *Roma*^*−/−*^ mid-gestation embryos. Immunoblot analysis of a panel of cell-cycle regulators recapitulated the observations in 10dL mammary glands ([Figure S3](#mmc1){ref-type="supplementary-material"}A), providing us with a tractable in vitro system. We investigated replication dynamics by pulse-labeling MEFs with iododeoxyuridine (IdU) followed by chlorodeoxyuridine (CldU) after which DNA fibers were spread and analyzed ([Figure 3](#fig3){ref-type="fig"}A). Surprisingly, *Roma*^*−/−*^ MEFs exhibited an approximately 45% increase in overall replication fork velocity compared to WT (1.6 ± 0.4 and 1.1 ± 0.02 kb/min, respectively) ([Figures 3](#fig3){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}B). Furthermore, in *Roma*^*−/−*^ MEFs, inter-origin distances were larger than in WT (130 ± 7 and 105 ± 4 kb, respectively) ([Figure 3](#fig3){ref-type="fig"}B). *Roma*^*−/−*^ MEFs are characterized by, on average, one less replication origin per megabase than WT MEFs (4.6/Mb and 6.1/Mb, respectively) ([Table S1](#mmc2){ref-type="supplementary-material"}), which could be a consequence of the faster moving forks in *Roma*^*−/−*^ cells inactivating adjacent replication origins ([@bib4]).

The increased replication fork speeds could result from failure to pause at DNA secondary structures and repetitive DNA sequences ([@bib24]) and could lead, potentially, to under-replicated areas, replication stress, and DNA damage response activation. Supporting this possibility, immunoblot analysis showed ATR/Chk1 and p53 activation ([Figure 3](#fig3){ref-type="fig"}C). These profiles are remarkably similar to those observed in mammary gland suggesting that aberrant DNA replication occurs also in the absence of *Roma* in vivo. Again, levels of p21^Cip1^ were not correspondingly upregulated to reinforce the G2/M checkpoint.

2D cell-cycle analysis of WT and *Roma*^*−/−*^ MEFs by pulse labeling with bromodeoxyuridine (BrdU) to identify cells in S phase revealed striking aneuploidy and polyploidy in *Roma*^*−/−*^ MEFs after only five passages ([Figures 3](#fig3){ref-type="fig"}D and [S3](#mmc1){ref-type="supplementary-material"}C). Measurement of the proportion of cells in either S phase (high BrdU content) or in G1/G2/M (low BrdU content) demonstrated that strikingly fewer *Roma*^*−/−*^ MEFs are in S phase (7%) compared to WT (35%). *Roma*^*−/−*^ MEFs also incorporated BrdU at a higher rate, consistent with them progressing faster through S phase.

During live-cell imaging of *Roma*^*−/−*^ MEFs, we noted that, while they are able to form the mitotic cleavage furrow characteristic of telophase, they subsequently fail to divide ([Movies S1](#mmc3){ref-type="supplementary-material"} and [S2](#mmc4){ref-type="supplementary-material"}). This impairment of cytokinesis in vitro correlates with elevated levels of Plk1, Aurora A, and securin ([Figure 3](#fig3){ref-type="fig"}E), that would impede sister chromatid separation. SAC components such as BubR1 are elevated in *Roma*^*−/−*^ MEFs ([Figure 3](#fig3){ref-type="fig"}E) as are levels of Mps1, which contributes to inhibition of proper mitotic exit in the presence of misaligned chromosomes ([@bib1]). Taken together, these observations suggest aberrant mitotic bypass and ploidy.

One possible interpretation of the increased fork velocities observed in Roma^−/−^ MEFs is that, in the absence of *Roma*, downregulation of p21^Cip1^ stabilizes interactions between PCNA and DNA polymerase δ ([@bib31]). p21^Cip1^ has a role also in facilitating fork pausing at natural barriers through interactions with PCNA and Fen1 ([@bib15]). Immunoprecipitation experiments in EpH4 normal MECs expressing a doxycycline-inducible Roma FLAG-tagged construct ([Figure 3](#fig3){ref-type="fig"}F) suggest that Roma interacts with Mcm2, Mcm3, and DNA Topoisomerase I although the binding domains required for these interactions have yet to be determined ([Figure S3](#mmc1){ref-type="supplementary-material"}D). We propose that loss of association between Roma and these key replication factors in *Roma*^*−/−*^ MEFs could potentially influence their recruitment and function at replication forks, contributing to an increase in replication fork speeds. This could lead to under-replication of some regions of the genome with coincident DNA damage that would activate the G2/M checkpoint enforced by p21^Cip1^. However, given the downregulation of p21^Cip1^ when Roma is ablated ([Figures 3](#fig3){ref-type="fig"}C and 3E), we posit that cells are able to bypass the checkpoint and enter mitosis. Furthermore, it has been shown that p21^Cip1^ is critical in preventing S phase entry after aberrant mitotic exit through cyclin E-CDK2 inhibition ([@bib33]). Hence, the downregulation of p21^Cip1^ would explain both the polyploidy and the continued cell-cycle progression in cells lacking Roma.

Another possible interpretation of the above data is that *Roma*^*−/−*^ cells are undergoing endoreduplication without appropriate cell division. The re-replication or endoreduplication of cells arrested in G2 is strongly enhanced by the loss of p21^Cip1^ ([@bib18]) or geminin ([@bib19]).

Overexpression of Roma Leads to Cell-Cycle Collapse {#sec2.4}
---------------------------------------------------

Next, we sought to investigate the impact of Roma overexpression in EpH4 normal MECs using a doxycycline-inducible Roma FLAG-tagged construct ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4C). Roma overexpression inhibited proliferation as evidenced by a decrease in total cell numbers over a 6-day time course ([Figure 4](#fig4){ref-type="fig"}A). Cell morphology was altered, with cells switching from a cuboidal epithelial form to a more elongated, spindle-shaped phenotype after prolonged induction of Roma expression ([Figure 4](#fig4){ref-type="fig"}B). Immunofluorescence analysis with an anti-FLAG antibody revealed an aggregation of Roma-FLAG into distinct foci after 24 hr doxycycline induction ([Figure S4](#mmc1){ref-type="supplementary-material"}D). These foci are reminiscent of replication foci ([@bib37]), supporting the involvement of Roma at the replication fork level.

BrdU analysis of EpH4 cells overexpressing Roma revealed that high levels of Roma led to S phase collapse with a lack of DNA synthesis ([Figure 4](#fig4){ref-type="fig"}C, top panel). It is striking that high levels of Roma do not lead to arrest at a specific cell-cycle phase but rather, cells are halted in G1, S, and G2/M. The sub-G1 population also suggests that Roma may induce cell death. Immunoblot analysis revealed a rapid increase in p21^Cip1^ levels within 6 hr that was independent of p53 activation ([Figures 4](#fig4){ref-type="fig"}D and [S4](#mmc1){ref-type="supplementary-material"}E). Transcriptional upregulation of p21^Cip1^ occurred within 4 hr of Roma expression being induced ([Figure 4](#fig4){ref-type="fig"}E, top panel). p21^Cip1^ can block origin firing by inhibiting CDK activity and binding PCNA, precluding its interaction with DNA polymerase δ ([@bib40]). p21^Cip1^ inhibition of G2, M, and G1 CDKs would further contribute to the full cell-cycle arrest observed. Another factor that was rapidly upregulated in response to Roma overexpression was geminin. Protein levels are increased after 8-hr induction ([Figure 4](#fig4){ref-type="fig"}D), while an increase in RNA was evident by 6 hr ([Figure 4](#fig4){ref-type="fig"}E, top panel). Increased geminin would arrest cells in late mitosis and G1 through Cdt1 inhibition and promotion of Cdt1 degradation by the E3 ubiquitin ligases SCF^Skp2^ and Cul4-Ddb1^Cdt2^, leading to the rapid decrease in Cdt1 levels observed ([Figure S4](#mmc1){ref-type="supplementary-material"}E).

Upon release from doxycycline, Roma levels decline rapidly, possibly by ubiquitin-mediated degradation ([Figure S4](#mmc1){ref-type="supplementary-material"}F), and cells previously arrested in S phase appear to resume replication within 2 hr of release ([Figure 4](#fig4){ref-type="fig"}C, bottom panel). p21^Cip1^ RNA and protein levels start to decrease by 4 and 6 hr, respectively ([Figure 4](#fig4){ref-type="fig"}E, bottom panel; [Figure S4](#mmc1){ref-type="supplementary-material"}G), independent of p53. Notably, arrested cells that re-enter the cell cycle appear to undergo endoreduplication after 6 hr ([Figure 4](#fig4){ref-type="fig"}C, bottom panel). Cells released from p21^Cip1^-induced G2 arrest undergo endoreduplication as p21^Cip1^ interferes with checkpoints that prevent re-entry into S phase without prior mitosis ([@bib28]). The cell death observed after 8 hr is likely the fate of endoreduplicating cells upon G1 checkpoint activation ([Figure 4](#fig4){ref-type="fig"}C, bottom panel).

Together, these results suggest that Roma overexpression rapidly, and reversibly, leads to S phase collapse and cell-cycle arrest. Given that p21^Cip1^ is transcriptionally upregulated when Roma is overexpressed, we knocked down p21^Cip1^ ([Figure S4](#mmc1){ref-type="supplementary-material"}H) and observed that this alleviated the cell-cycle arrest induced by Roma overexpression, suggesting that excess Roma can mediate S phase arrest primarily through upregulation of p21^Cip1^ ([Figure 4](#fig4){ref-type="fig"}F). However, since p21^Cip1^ knockdown did not completely prevent cell-cycle arrest but rather led to an accumulation of cells in G1, we suggest that geminin, which is also transcriptionally regulated by Roma (data not shown) could be responsible for blocking S phase entry by inhibiting replication licensing ([Figures 4](#fig4){ref-type="fig"}D and 4E). Clearly, levels of Roma need to be exquisitely regulated in order to maintain cell-cycle progression with excess, or insufficient, Roma resulting in cell-cycle arrest or unscheduled DNA replication and genomic instability.

Discussion {#sec3}
==========

KRAB-domain zinc finger proteins (KRAB-Zfps) comprise a large family of rapidly evolving DNA binding proteins that are unique to tetrapods and impart tissue specific functions ([@bib39]). Roma is a KRAB-Zfp with a previously unsuspected role as a regulator of mammalian cell-cycle progression through modulation of multiple cell-cycle components and control of replication fork velocity. We have identified p21^Cip1^ and geminin as critical downstream targets of Roma and demonstrated physical interaction between Roma and components of the replication machinery such as Mcm2/3 and DNA Topoisomerase I. Loss of Roma results in increased replication fork speeds and checkpoint bypass resulting in polyploidy and genomic instability. This could predispose to tumorigenesis, and our previous study showed that Roma deficiency results in hyperplasia in mammary alveolar cells that have been depleted also of Gata3 ([@bib29]).

We show that the quiescence associated with differentiated MECs during lactation is dependent on appropriate levels of Roma. p21^Cip1^ has long been implicated in terminal differentiation of multiple cell types: skeletal muscle myogenesis is associated with p21^Cip1^ upregulation ([@bib13]), and p21^Cip1^-deficient keratinocytes exhibit reduced differentiation ([@bib26]). Absence of p21^Cip1^ has been implicated in enhancing appendage regeneration in mice through unscheduled S phase entry ([@bib3]). Likewise, in mammary gland development, Roma regulation of p21^Cip1^ might be important in inducing quiescence in secretory epithelial cells during lactation. Furthermore, Roma is expressed at higher levels in basal epithelial cells, which cycle less frequently than luminal cells ([@bib42]).

Apart from preventing re-licensing and re-replication, geminin prevents over-cycling and exhaustion of multipotent progenitor populations and promotes genomic stability in long-term repopulating hematopoietic stem cells by inducing quiescence ([@bib36]). The transcriptional downregulation of geminin in the absence of Roma might be another contributing factor in the failure of *Roma*^*−/−*^ MECs in lactating glands to enter G0. Interestingly, in human breast tissue, there is a lack of correlation between Mcm2--7 levels and markers of proliferation with one study showing that more than 50% of breast epithelial cells expressed Mcm2--7, although only 6% were proliferative ([@bib35]). Thus, unlike other tissues, most breast epithelial cells are licensed but not actively cycling. This could render the mammary gland particularly sensitive to changes in the relative levels of cell-cycle regulators such as geminin and p21^Cip1^. Hence, appropriate regulation of geminin by Roma could be essential as a safeguard against mammary tumorigenesis. We suggest that Roma and Stat6 interact in a negative transcriptional regulatory loop whereby Stat6 suppresses Roma expression specifically in luminal cells during pregnancy to allow elevated levels of proliferation while maintaining sufficient levels of Roma to prevent unscheduled DNA replication. Roma may have an additional role as an integral component of the replication fork, a notion that will require further investigation.

Although not described in mammary gland, physiological instances of re-replication and accumulation of polyploid cells do exist in the form of trophoblast giant (TG) cells and megakaryocytes, which have DNA contents between 8N to 64N. This results from endoreduplication in TG cells and endomitosis in megakaryocytes and has been associated with inhibition of CDK1 activity by p57, and suppression of DNA damage signaling by p21^Cip1^ ([@bib38]). However, under non-physiological conditions, inactivation of p21^Cip1^ can enhance endoreduplication, albeit leading to apoptosis ([@bib16]). The switch from mitotic cycles to endocycles has been linked to the degradation and loss of factors critical for mitotic entry such as cyclin B1, Plk1, and Aurora B by APC^Cdh1^ ([@bib8]). However, given the upregulation of these factors in the absence of *Roma*, the accumulation of polyploid cells is likely to be a consequence of checkpoint escape and cell division failure.

We suggest, therefore, that Roma has a critical role in determining whether a cell can progress unperturbed through the cell division cycle and is required at precise stoichiometric levels in late G1/S phase to control replication fork progression. Roma appears also to be required in G2/M phase to ensure completion of cell division and genomic stability. The observation of hyperproliferation in gut, thymus, and spleen of *Roma*^*−/−*^ mice implies a wider role for this transcriptional regulator. The identification of a critical role for Roma in controlling proliferation and genomic stability suggests that Roma may be a tumor suppressor, particularly in the breast, and awaits further studies.

Experimental Procedures {#sec4}
=======================

Animals {#sec4.1}
-------

Roma knockout mice were generated as described ([@bib29]). 7- to 8-week old virgin female mice were mated and plug-checked to confirm pregnancy. All animals were treated according to the local ethical committee (AWERB) and the UK Home Office guidelines.

Tissue Sections and Immunofluorescence {#sec4.2}
--------------------------------------

Tissues were collected from abdominal glands and fixed in 4% paraformaldehyde overnight and stored in 70% ethanol. Tissues were embedded in wax and sectioned at 4-μm thickness. Sections were deparaffinized, and antigen was retrieved and stained as described in [@bib29]. Antibodies used were E-cadherin (BD Pharmingen, \#610182), RPA32/RPA2 (pT21; Abcam, ab109394), H2AX (pS139; Millipore, 05-636), 53BP1 (Novus Biologicals, NB100-304), and DYKDDDDK Tag (Cell Signaling Technology, \#2368). Slides were visualized with a Zeiss confocal microscope.

PCR {#sec4.3}
---

RNA extraction of mammary tissue was carried out as described ([@bib29]). RT-PCR was performed using 2 μl of cDNA, and samples were cycled 27 times. Parameters were 95°C 5 min; 95°C 30 s, 60°C 30 s, 72°C 30 s; 72°C 7 min; 4°C hold. Primers used were p21^Cip1^ forward (GCAGATCCACAGCGATATC); reverse (CAACTGCTCACTGTCCACG); Geminin forward (GGAGCATTGCTGTCTCTGAA); reverse (TCTTCAGCGTTCTCCTTGGG).

Immunoblotting {#sec4.4}
--------------

Western blotting was performed as described ([@bib29]). Antibodies used were Cyclin D1 (Cell Signaling Technology, \#2978), PCNA (Santa Cruz Biotechnology, sc-56), Geminin (Santa Cruz Biotechnology, FL-209), RPA32/RPA2 (pT21) (Abcam, ab109394), H2AX (pS139) (Millipore, 05-636), p53 (Santa Cruz Biotechnology, sc-126), p21 (BD Pharmingen, \#556430), MDM2 (BD Pharmingen, \#556353), DYKDDDDK Tag (Cell Signal, \#2368), E2F1 (Bethyl, A300-766A), p53 (pS15) (Cell Signal, \#9284), MDC1 (Bethyl, A300-053A), Cyclin E (Cell Signal, \#4129), ATR (pS428) (Cell Signal, \#2853), CHK1 (pS345) (Cell Signal, \#2341), RAD51 (Abcam, ab63801), Cyclin B1 (Abcam, ab52187), Cdc6 (Santa Cruz Biotechnology, sc-8341), ORC3 (Santa Cruz Biotechnology, sc-23888), DNA polα (Santa Cruz Biotechnology, sc-365039), Cdk2 (Santa Cruz Biotechnology, sc-163), Cdk1 (Abcam, ab18), Wee1 (Abcam, ab137377), Rb (Santa Cruz Biotechnology, sc-50), Cdh1 (Abcam, ab154539), Cdc20 (Cell Signal, \#4823), Securin (Abcam, ab3305), GINS (Santa Cruz Biotechnology, sc-373595), Cdc45 (Santa Cruz Biotechnology, sc-20685), Aurora A (Cell Signal, \#3092), Plk1 (Abcam, ab17056), Gadd45 (Cell Signal, \#4632), Emi1 (Santa Cruz Biotechnology, sc-30182), BubR1 (Santa Cruz Biotechnology, sc-16195), ATM (BD Pharmingen, 560007), ATM (pS1981) (Cell Signal, \#4526), CHK2 (pT68) (Cell Signal, \#16297), Cdt1 (Stavros Taraviras), and MCM3 (Nick Coleman).

Primary Mammary Cell and Metaphase Preparation {#sec4.5}
----------------------------------------------

Cells were isolated from mammary glands after a full natural wean according to [@bib34] and cultured in complete media consisting of 10% fetal calf serum (FCS) in DMEM, gentamicin, 5 μg/ml insulin, and 10 ng/ml murine epidermal growth factor. Cells were treated with 0.1 μg/ml of nocodazole (Sigma-Aldrich). Cells were pelleted and 7ml of pre-warmed 0.05M KCl was added with gentle swirling followed by incubation for 12 min at 37°C. 10 ml of 3:1 methanol:acetic acid fixative was added dropwise before pelleting cells. R e-suspension in 5ml 3:1 methanol:acetic acid fixative was repeated thrice before cells were re- suspended in 2ml of 3:2 methanol:acetic acid fixative.

Primary MEF Preparation {#sec4.6}
-----------------------

13.5-day-old embryos were harvested. Viscera were dissected away and carcasses were cut into small fragments. 3 ml trypsin/EDTA was added and incubated for 5 min at 37°C. Plates were rinsed with 5 ml 10% FCS in DMEM with gentamicin. Cells were re-suspended in 2 ml trypsin/EDTA and incubated for 5 min at 37°C. 8 ml of media was added and mixed by inversion before plating.

In Vivo EdU Injections {#sec4.7}
----------------------

500 μg of EdU (5-ethynyl-2′-deoxyuridine; Life Technologies) was administered at the various time points stated via intra-peritoneal injection 24 hr prior to tissue collection. Tissues were fixed in 4% paraformaldehyde for 2 hr at room temperature before transferring to 70% ethanol. Detection of EdU was done with the Click-iT EdU imaging kit (Invitrogen) as per manufacturer's instructions.

Overexpression of Roma-FLAG in EpH4 Cells {#sec4.8}
-----------------------------------------

Roma-FLAG was cloned into a PiggyBac transposon system, and EpH4 cells were transfected via the Amaxa nucleofector protocol (Lonza) as per manufacturer's instructions.

Immunoprecipitation {#sec4.9}
-------------------

Cells were harvested by scraping in cold PBS and re-suspended in RIPA lysis buffer with protease inhibitor cocktail. 2 mg of protein was used per immunoprecipitation. Anti-FLAG M2 affinity gel (Sigma-Aldrich, A2220) was prepared as per manufacturer's instructions and incubated with protein lysate overnight at 4°C with rotation. For immunoprecipitation with anti-Mcm2 (BD Transduction, 610700) and anti-DNA-TopI (Abcam, ab3825), Protein G sepharose 4 Fast Flow (GE Healthcare, GE17-0618-02) was used.

Small Interfering RNA {#sec4.10}
---------------------

ON-TARGETplus SMARTpool small interfering RNA (siRNA) against p21/Cdkn1a (Dharmacon, L-058636-00-0005) and ON-TARGETplus Non-targeting pool siRNA (Dharmacon, D-001810-10-05) as negative control were used.

Cell-Cycle Analysis with BrdU {#sec4.11}
-----------------------------

Cell-cycle analysis was done as described ([@bib11]) with the minor modification that MEFs were trypsinized after the 30-min BrdU incorporation.

Preparation, Spreading, and Immunolabeling of DNA Fibers {#sec4.12}
--------------------------------------------------------

DNA fiber spreading was done as described ([@bib11]) with minor modifications as follows: MEFs were incubated with 25 μM IdU for 15 min and supplied with fresh medium containing 25 μM CldU for another 15 min. Cells were trypsinized with 10× trypsin. Immunostaining and analysis were carried out as described ([@bib12]).

Statistical Analysis {#sec4.13}
--------------------

Statistical significance was assessed using unpaired two-tailed Student's t tests in Microsoft Excel (TTEST).

Author Contributions {#sec5}
====================

T.L.F.H. carried out the majority of the experiments except for the DNA fiber analyses, which were performed by G.G. T.L.F.H., G.G., J.J.B., J.E.S., and C.J.W. designed the work, analyzed the data, and wrote the manuscript.
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(A) Immunofluorescence analysis of EdU incorporation in mammary gland tissue sections from WT and *Roma*^*−/−*^ mice at 5dG and 10dL, 24 hr following injection in vivo. Scale bars, 10 μm. The number of EdU^+^ and EdU^--^ cells was counted and presented as an average percentage. Data are presented as the mean, and error bars represent SD (5dG: p = 9.52E−04, 10dL: p = 2.49E−05, Student's t test).\
(B) Protein extracts were prepared from WT and *Roma*^*−/−*^ glands at 10dL followed by immunoblot analysis of cell-cycle factors as indicated. Protein extract from 5dG WT gland was used as a proliferation control.\
(C) PCR and quantitative real-time PCR analysis of geminin in extracts from 10dL WT and *Roma*^*−/−*^ glands (p = 0.0002, Student's t test).\
(D) Immunofluorescence analysis of E-cadherin staining (green) with binucleate cells indicated (white arrows). Nuclei are stained with DAPI (blue). Scale bars, 10 μm.\
(E) Immunoblot analysis of cell-cycle factors in extracts of WT and *Roma*^*−/−*^ glands at 10dL. Protein extract from 5dG WT gland was used as a proliferation control.\
(F) Primary MECs were isolated from WT and *Roma*^*−/−*^ glands at full wean, and metaphase spreads were prepared. Karyotype analysis was carried out, and tetraploidy was determined by counting the number of chromosomes.\
See also [Figure S1](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![Absence of *Roma* Leads to Activation of the DNA Damage Response and Genomic Instability\
(A) Representative immunofluorescence analysis of RPA2-pT21, γH2AX, and 53BP1 foci in tissue sections from WT and *Roma*^*−/−*^ glands at 10dL. The white arrow indicates nucleolar γH2AX. Scale bars, 10 μm. The higher magnification panels on the right have been chosen to highlight the foci and are not zoomed images of the left panels.\
(B) Immunoblot analysis of cell-cycle checkpoint and DNA damage response in extracts from WT and *Roma*^*−/−*^ glands at 10dL. Extracts from U2OS cells treated with 5mM HU were used as a damage control.\
(C) PCR analysis of p21^Cip1^ and MDM2 and quantitative real-time PCR analysis of p21^Cip1^ in extracts from 10dL WT and *Roma*^*−/−*^ glands (p = 0.0007, Student's t test).\
(D) Representative spectral karyotypes (top) and metaphase spreads (bottom panel) prepared from MECs isolated from WT and *Roma*^*−/−*^ glands after a full natural wean.\
See also [Figure S2](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![Altered Replication Dynamics and Aneuploidy in *Roma*-Deficient Cells\
(A) Primary MEFs were isolated from WT and *Roma*^*−/−*^ embryos and cultured in vitro. DNA fibers from these cells were spread and stained with antibodies to IdU and CldU and counterstained with anti-DNA antibodies to ensure that broken fibers were not analyzed. Replication fork velocities were then measured. Data are presented as mean ± SD.\
(B) Interorigin distances in WT and *Roma*^*−/−*^ MEFs were measured. Data are presented as mean ± SD.\
(C) Protein extracts were prepared from WT and *Roma*^*−/−*^ primary MEFs followed by immunoblot analysis of markers of cell-cycle checkpoints and the DNA damage response. Extract from U2OS cells treated with 5 mM HU was used as a damage control.\
(D) Primary WT and *Roma*^*−/−*^ MEFs were pulsed with BrdU, and cell-cycle analysis was conducted. Percentage of cells in G1/G2/M and S phases was calculated.\
(E) Immunoblot analysis of cell-cycle factors. Protein extract from 5dG WT gland was used as a proliferation control.\
(F) EpH4 cells were transfected with a Roma-FLAG expression construct and cultured under puromycin selection. Doxycycline was used to induce Roma-FLAG expression. Protein extracts were prepared from EpH4 cells under the stated conditions followed by FLAG immunoprecipitation and immunoblot against Mcm2, Mcm3, and DNA Topoisomerase I showing association with Roma-FLAG.\
See also [Figure S3](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![Overexpression of Roma Results in S Phase Arrest\
(A) EpH4 cells were transfected with a Roma-FLAG expression construct and cultured under puromycin selection. Doxycycline was used to induce Roma-FLAG expression. Cell counts were monitored over the course of a week and represented in a graph.\
(B) Representative images of cells under the indicated conditions.\
(C) EpH4 cells transfected with a Roma-FLAG expression construct were treated with doxycycline at a series of time points and then released from doxycycline and pulsed with BrdU followed by flow cytometry analysis.\
(D) Protein extracts were prepared from EpH4 cells at conditions stated and immunoblot analysis of cell-cycle checkpoint, and DNA damage response markers was conducted.\
(E) RNA was extracted from EpH4 cells cultured in conditions stated followed by PCR analysis of p21Cip1.\
(F) EpH4 cells cultured in conditions stated were treated with p21Cip1 siRNA and pulsed with BrdU followed by cell-cycle analysis using flow cytometry.\
See also [Figure S4](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}
